dabigatran has been researched along with bithionol in 1 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (bithionol) | Trials (bithionol) | Recent Studies (post-2010) (bithionol) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 203 | 3 | 43 |
| Protein | Taxonomy | dabigatran (IC50) | bithionol (IC50) |
|---|---|---|---|
| Mcl-1 | Homo sapiens (human) | 1.7844 | |
| Estrogen receptor 1 | Homo sapiens (human) | 3.9409 | |
| envelope glycoprotein | Human immunodeficiency virus 1 | 6.16 | |
| estrogen receptor beta isoform 1 | Homo sapiens (human) | 8.1472 | |
| Solute carrier family 22 member 2 | Homo sapiens (human) | 1.9 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 3.065 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 8.78 | |
| Solute carrier family 22 member 3 | Homo sapiens (human) | 5.5 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.614 | |
| Transthyretin | Homo sapiens (human) | 2.7 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 2.147 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 2.255 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.235 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 1.67 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 1.67 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 1.67 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 1.67 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.824 | |
| Adenosine receptor A3 | Homo sapiens (human) | 0.829 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 2.8 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 1.67 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.829 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 1.226 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 4.392 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 5.515 | |
| Substance-K receptor | Homo sapiens (human) | 4.659 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.235 | |
| Thromboxane-A synthase | Homo sapiens (human) | 1.84 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 8.78 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.385 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 5.515 | |
| Adenosine receptor A2a | Homo sapiens (human) | 1.167 | |
| Mu-type opioid receptor | Homo sapiens (human) | 5.507 | |
| D(3) dopamine receptor | Homo sapiens (human) | 4.218 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 6.789 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.829 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 2.8 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.181 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.318 | |
| 60 kDa chaperonin | Escherichia coli | 4.3 | |
| 10 kDa chaperonin | Escherichia coli | 4.3 | |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 6.6 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 5.2 | |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 42.88 | |
| large T antigen | Betapolyomavirus macacae | 35.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
1 other study(ies) available for dabigatran and bithionol
| Article | Year |
|---|---|
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |